LCD L39680: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Noridian
Policy LCD-L39680 · Pulmonology
New guidelines may improve billing for pulmonary nodule tests.
Code intelligence
R91.8 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code R91.8.
Elevated code riskView ICD-10 detail
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
2
High
33%
4
Routine
67%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39678: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Noridian
Policy LCD-L39678 · Pulmonology
New MolDX guidelines will impact pulmonary nodule billing practices.
LCD L37549: Chest X-Ray Policy — Noridian
Policy LCD-L37549 · Radiology
Understand the impact of the Chest X-Ray policy.
LCD L37897: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer — Noridian
Policy LCD-L37897 · Oncology
New liquid biopsy tests for lung cancer impact billing.
LCD L39711: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — WPS
Policy LCD-L39711 · Pulmonology
New LCD on molecular biomarkers for pulmonary nodules.
LCD L37547: Chest X-Ray Policy — Noridian
Policy LCD-L37547 · Radiology
Prepare for changes in Chest X-Ray billing from 2025.
Audit documentation
Building an audit file that includes R91.8?
The Tripwire Audit Pack exports 12 months of Pulmonology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Pulmonology audit pack — $349One-time purchase · not a subscription